$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Risk factors for chronic rejection - a clinical perspective

Transplant immunology, v.6 no.1, 1998년, pp.1 - 11  

Matas, Arthur J (Address for correspondence: AJ Matas, BOX 328, 420 Delaware Street SE, Minneapolis, MN 55455, USA.)

초록이 없습니다.

참고문헌 (94)

  1. Ann Surg Schweitzer 214 679 1991 10.1097/00000658-199112000-00007 Cause of renal allograft loss: progress in the '80s, challenges for the '90s 

  2. Transplantation Burke 60 1413 1995 10.1097/00007890-199560120-00007 Chronic renal allograft rejection in the first 6 months posttransplant 

  3. Clin Transplantation Matas 8 332 1994 Chronic rejection in renal transplant recipients - risk factors and correlates 

  4. Am J Physiol Hostetter 241 F85 1981 Hyperfiltration in remnant nephrons: a potentialy adverse response to renal ablation 

  5. J Am Soc Nephrol Brenner 3 162 1992 10.1681/ASN.V32162 In renal transplantation, one size may not fit all 

  6. Transplantation Terasaki 57 1450 1994 10.1097/00007890-199405000-00008 The hyperfiltration hypothesis in human renal transplantation 

  7. Transplantation Basadonna 55 993 1993 10.1097/00007890-199305000-00007 Early versus late acute renal allograft rejection: impact on chronic rejection 

  8. Transplantation Almond 55 752 1993 10.1097/00007890-199304000-00013 Risk factors for chronic rejection in renal allograft recipients 

  9. Pediatr Nephrol Laine 10 221 1996 10.1007/BF00862088 Chronic rejection and late renal allograft dysfunction 

  10. Transplantation Tullius 59 313 1995 10.1097/00007890-199502150-00001 Both alloantigen-dependent and -independent factors influence chronic allograft rejection 

  11. Transplant Immunol Paul 4 39 1996 10.1016/S0966-3274(96)80031-1 Immunological and hemodynamic mechanisms in chronic renal allograft rejection 

  12. Clin Transplantation Paul 8 319 1994 Functional and histologic characteristics of chronic renal allograft rejection 

  13. Clin Invest Hayry 70 780 1992 10.1007/BF00180748 Towards understanding the pathophysiology of chronic rejection 

  14. Transplantation Vianello 59 1504 1995 10.1097/00007890-199505270-00030 Pros and cons of the hyperfitration theory in human renal transplantation 

  15. Transplantation Spital 62 1356 1996 10.1097/00007890-199611150-00031 Health insurance for kidney donors: how easy is it do obtain? 

  16. Kidney Int Kasiske 40 514 1991 10.1038/ki.1991.240 Histopathologic findings associated with a chronic, progressive decline in renal alograft function 

  17. J Am Med Assoc Chertow 276 1732 1996 10.1001/jama.276.21.1732 Antigen-independent determinants of cadaveric kidney transplants failure 

  18. Transplantation Troppman 59 962 1995 10.1097/00007890-199504150-00007 Delayed graft function, acute rejection, and outcome after cadaver renal transplantation - a multivariate analysis 

  19. Transplant Proc Troppmann 23 1365 1991 Donor age and cause of death affect cadaver renal allograft outcome 

  20. Presented at the Sixteenth Annual American Society of Transplant Physicians Kerr 1997 Living donors (LD's) age τ55; to use or not to use 

  21. Transplant Proc Cecka 23 1263 1991 Early rejection: determining the fate of renal transplants 

  22. Transplantation Gulanikar 53 323 1992 10.1097/00007890-199202010-00013 The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants 

  23. American Society of Transplant Surgeons, 18th Annual Scientific Meeting Ferguson 83 1992 Acute rejection episodes-best predictor of long-term primary cadaveric renal transplant survival 

  24. Transplantation Matas 57 857 1994 10.1097/00007890-199403270-00015 The impact of an acute rejection episode on long-term renal allograft survival (t12 

  25. Transplantation Matas 55 757 1993 10.1097/00007890-199304000-00014 Half-life and risk factors for kidney transplant outcome - importance of death with function 

  26. Transplant Proc Lindholm 22 1429 1990 Differential effects of peritransplant variables on short- and predicted long-term outcome in cyclosporine-treated recipients of cadaveric renal allografts 

  27. Transplantation Lindholm 56 307 1993 10.1097/00007890-199308000-00010 The impact of acute ejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by three cyclosporine regimens 

  28. Surgery Knechtle 120 719 1996 10.1016/S0039-6060(96)80022-5 Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation 

  29. Transplantation Leggat 63 1268 1997 10.1097/00007890-199705150-00013 Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes 

  30. Transplantation Flechner 62 1235 1996 10.1097/00007890-199611150-00009 Determinants of chronic renal allograft rejection in cyclosporine-treated recipients 

  31. Transplantation Tejani 61 1054 1996 10.1097/00007890-199604150-00011 Clinical correlates of chronic rejection in pediatric renal transplantation: a report of the North American Renal Transplant Cooperative Study 

  32. Transplant Proc Opelz 29 73 1997 10.1016/S0041-1345(96)00013-9 Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients 

  33. J Am Soc Nephrol Chavers 6 1076 1995 Histology of acute rejection (AR) impacts renal allograft survival (GS) in patients (pts) with a single rejection episode (SRE) 

  34. Transplantation Van Saase 59 1280 1995 10.1097/00007890-199505000-00010 The relation between acute vascular interstital renal allograft rejection and subsequent chronic rejection 

  35. Kidney Int Massy 49 518 1996 10.1038/ki.1996.74 Chronic renal allograft rejection: immunologic and nonimmunologic risk factors 

  36. Transplantation Cosio 53 1611 1997 10.1097/00007890-199706150-00013 Impact of acute rejection and early allograft function on renal allograft survival 

  37. Transplantation Vereerstraeten 63 1739 1997 10.1097/00007890-199706270-00006 Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery 

  38. Transplantation Zantvoort 61 841 1996 10.1097/00007890-199603150-00030 The impact of HLA-A matching on long-term survival of renal allografts 

  39. Transplantation Pirsch 61 1581 1996 10.1097/00007890-199606150-00006 Determinants of graft survival after renal transplantation 

  40. Transplantation Isoniemi 58 1195 1994 10.1097/00007890-199412000-00010 Histological chronic allograft damage index accurately predicts chronic renal allograft rejection 

  41. Transplantation Isoniemi 57 68 1994 10.1097/00007890-199401000-00013 Risk factors predicting chronic rejection of renal allografts 

  42. Cecka 1-18 1994 The UNOS scientific renal transplant registry 

  43. Pediatr nephrol Guyot 10 723 1996 10.1007/s004670050199 Risk factors for chronic rejection in pediatric renal allograft recipients 

  44. Pediatr Nephrol Birk 11 395 1997 10.1007/s004670050303 Risk factors for chronic rejection in pediatric renal transplant recipients - a single-center experience 

  45. Hepatology Donaldson 17 1008 1993 10.1002/hep.1840170611 Influence of human leukocyte antigen matching on liver allograft survival and rejection: the dualistic effect 

  46. Lancet O'Grady 6 302 1988 10.1016/S0140-6736(88)92356-2 Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation 

  47. Lancet Candinas 346 1117 1995 10.1016/S0140-6736(95)91797-7 Sex mismatch as a risk factor for chronic rejection of liver allografts 

  48. Hepatology Arnold 16 285 1992 10.1002/hep.1840160202 Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome 

  49. Transplantation Manez 55 1067 1993 10.1097/00007890-199305000-00024 The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation 

  50. Hepatology Lautenschlager 25 190 1997 10.1002/hep.510250135 Persistent cytomegalovirus in liver allografts with chronic rejection 

  51. Hepatology Freese 13 882 1991 10.1002/hep.1840130514 Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features 

  52. Hepatology Wiesner 14 721 1991 10.1002/hep.1840140424 Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure 

  53. Transplantation Devlin 56 1381 1993 10.1097/00007890-199312000-00020 Ethnic variations in patient and graft survival after liver transplantation 

  54. Transplantation Scott 51 813 1991 10.1097/00007890-199104000-00015 Risk factors for obliterative bronchiolitis in heart-lung transplant recipients 

  55. Transplantation Sharples 61 560 1996 10.1097/00007890-199602270-00008 Development of bronchiolitis obliterans syndrom in recipients of heart-lung transplantation - early risk factors 

  56. Clin Chest Med Paradis 4 751 1993 10.1016/S0272-5231(21)00937-0 Alrway obstruction and bronchiolitis obliterans after lung transplantation 

  57. Transplant Int Cerrina 5 S242 1992 10.1111/tri.1992.5.s1.242 Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients 

  58. Chest Surg Clin N Am Keenan 5 107 1995 Immunologic consequences of transplantation 

  59. Transplantation Keenan 51 433 1991 10.1097/00007890-199102000-00032 Cytomegalvirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation 

  60. Transplantation Yousem 52 306 1991 10.1097/00007890-199108000-00023 Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? 

  61. Clin Transplantation Koskinen 10 487 1996 Cytomegalovirus infection associated with accelerated heart allograft arteriosclerosis may impair the late function of the graft 

  62. J Heart Lung Transplant Koskinen 12 724 1992 Cytomegalovirus infection and accelarated cardiac allograft vasculopathy in human cardiac allografts 

  63. J Am Med Assoc Grattan 261 3561 1989 10.1001/jama.261.24.3561 Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis 

  64. J Heart Transplant Loebe 6 707 1990 Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart 

  65. J Heart Lung Transplant Durham 14 774 1995 Persistence of interstitial inflammation after episodes of cardiac rejection associated with systemic infection 

  66. Hepatology Paya 16 66 1992 10.1002/hep.1840160113 Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after live transplantation 

  67. Transplantation Schweizer 49 374 1990 10.1097/00007890-199002000-00029 Noncompliance in organ transplant recipients 

  68. Transplantation Dunn 49 349 1990 10.1097/00007890-199002000-00024 Causes of graft loss beyond two years in the cyclosporine era 

  69. Transplant Proc Didlake XX 63 1988 Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants 

  70. J Appl Social Psychol Rudman 1988 Mishandling the gift of life: noncompliance in renal transplant patients 

  71. Transplantation DeGeest 59 340 1995 10.1097/00007890-199502000-00006 Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients 

  72. Nevins 26 1996 

  73. Transplant Proc Baldwin XIII 1547 1981 Antibodies to endothelial antigens in eluates of 88 human kidneys: correlation with graft survival and presence of T- and B-cell antibodies 

  74. Transplantation Mohanakumar 32 61 1981 10.1097/00007890-198107000-00013 Serological characteristics of antibodies eluted from chronically rejected human renal allografts 

  75. Transplantation Suciu-Foca 51 593 1991 10.1097/00007890-199103000-00011 Soluble HLA-antigens, anti-HLA antibodies and anti-idiotypic in the circulation of renal transplant recipients 

  76. Transplantation Suciu-Foca 51 716 1991 10.1097/00007890-199103000-00033 Role of anti-HLA antibodies in heart transplantation 

  77. Trasnplantation Reed 61 566 1996 10.1097/00007890-199602270-00009 Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease 

  78. Lancet Dunn 339 1566 1992 10.1016/0140-6736(92)91832-S Antiendothelial antibodies and coronary artery disease after cardiac transplantation 

  79. Transplant Immunol Ferry 5 17 1997 10.1016/S0966-3274(97)80021-4 Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: associatin with chronic rejection 

  80. Transplantation Abe 63 1616 1997 10.1097/00007890-199706150-00014 Postoperative production of anti-donor antibody and chronic rejection in renal transplantation 

  81. Transplant Proc Reinsmoen 25 3277 1993 Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplant 

  82. J Heart Lung Transplant Reinsmoen 13 30 1994 Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity 

  83. Transplant Proc Reinsmoen 26 2558 1994 Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity 

  84. Transplantation Reinsmoen 55 1017 1993 10.1097/00007890-199305000-00013 Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity 

  85. Reinsmoen NL, Troppman C, Matas AJ. Risk factors for chronic rejection: influence of donor antigen-specific responder status. Submitted. 

  86. Lancet Starzl 339 1579 1992 10.1016/0140-6736(92)91840-5 Cell migration, Chimerism, and graft acceptance 

  87. Hepatology Starzl 17 1127 1993 10.1002/hep.1840170629 Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance 

  88. Immunol Today Starzl 17 577 1996 10.1016/S0167-5699(96)10070-0 The lost chord: microchimerism and allograft survival 

  89. E Engl J Med Schlitt 328 646 1994 10.1056/NEJM199403033300919 Donor-type microchimerism associated with graft rejection eight years after liver transplantation 

  90. Lancet Suberbielle 343 1468 1994 10.1016/S0140-6736(94)92583-6 Peripheral Microchimerism in long-term cadaveric-kidney allograft recipients 

  91. Transplantation Sivasia 64 427 1997 10.1097/00007890-199708150-00010 Peripheral blood microchimerism in human liver and renal transplant recipients 

  92. 15th Annual Scientific Meeting of the American Society of Transplant Physicians Reinsmoen 1997 Donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimersm as predictors of a chronic rejection-free state in lung and heart recipients 

  93. 22nd Annual Meeting of the American Society of Histocompatibility and Immunogenetics Jackson 1996 Peripheral Blood allogeneic microchimerism 2 years postransplant is associated with a lower incidence of coronary artery disease in heart recipients 

  94. Kidney Int Hunsicker 48 S120 1995 Design of trials of methods to reduce late renal allograft loss: the price of success 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로